Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval    crawled time : 01:10    save search
HUMIRA® (adalimumab) Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis
Published: 2021-02-25 (Crawled : 01:10) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
 | | O: -0.19% H: 0.76% C: -1.06%
fda fda approval approval ulcerative colitis
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.